APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Repair Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global DNA Repair Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchDNA Repair Drugs Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Repair Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal DNA Repair Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Repair Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Repair Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global DNA Repair Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DNA Repair Drugs include Johnson & Johnson, Jiangsu Hengrui Medicine, GlaxoSmithKline, Tesaro, National Institutes of Health, National Health Service, KuDOS Pharmaceuticals, Karyopharm Therapeutics and Jonsson Comprehensive Cancer Center, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DNA Repair Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Repair Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Repair Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Repair Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

DNA Repair Drugs Segment by Company

Johnson & Johnson

Jiangsu Hengrui Medicine

GlaxoSmithKline

Tesaro

National Institutes of Health

National Health Service

KuDOS Pharmaceuticals

Karyopharm Therapeutics

Jonsson Comprehensive Cancer Center

German Breast Group

Georgetown University

Genentech

Cambridge University Hospitals NHS Foundation Trust

British Columbia Cancer Agency

Bristol Myers Squibb

ARCAGY/ GINECO GROUP

4SC AG

DNA Repair Drugs Segment by Type

PARP Inhibitors

Other

DNA Repair Drugs Segment by Application

Oncological

Stroke

DNA Repair Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Repair Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Repair Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Repair Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DNA Repair Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of DNA Repair Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of DNA Repair Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. DNA Repair Drugs Industry Trends Table 2. DNA Repair Drugs Industry Drivers Table 3. DNA Repair Drugs Industry Opportunities and Challenges Table 4. DNA Repair Drugs Industry Restraints Table 5. Global DNA Repair Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global DNA Repair Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global DNA Repair Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global DNA Repair Drugs Sales Market Share by Manufacturers Table 9. Global DNA Repair Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global DNA Repair Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global DNA Repair Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global DNA Repair Drugs Manufacturers, Product Type & Application Table 13. Global DNA Repair Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global DNA Repair Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PARP Inhibitors Table 17. Major Manufacturers of Other Table 18. Global DNA Repair Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global DNA Repair Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global DNA Repair Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global DNA Repair Drugs Sales Market Share by Type (2021-2026) Table 22. Global DNA Repair Drugs Sales Market Share by Type (2027-2032) Table 23. Global DNA Repair Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global DNA Repair Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global DNA Repair Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global DNA Repair Drugs Revenue Market Share by Type (2021-2026) Table 27. Global DNA Repair Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Oncological Table 29. Major Manufacturers of Stroke Table 30. Global DNA Repair Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global DNA Repair Drugs Sales by Application (2021-2026) & (K Units) Table 32. Global DNA Repair Drugs Sales by Application (2027-2032) & (K Units) Table 33. Global DNA Repair Drugs Sales Market Share by Application (2021-2026) Table 34. Global DNA Repair Drugs Sales Market Share by Application (2027-2032) Table 35. Global DNA Repair Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global DNA Repair Drugs Revenue by Application (2021-2026) & (K Units) Table 37. Global DNA Repair Drugs Revenue by Application (2027-2032) & (K Units) Table 38. Global DNA Repair Drugs Revenue Market Share by Application (2021-2026) Table 39. Global DNA Repair Drugs Revenue Market Share by Application (2027-2032) Table 40. Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global DNA Repair Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global DNA Repair Drugs Sales Market Share by Region (2021-2026) Table 43. Global DNA Repair Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global DNA Repair Drugs Sales Forecasted Market Share by Region (2027-2032) Table 45. North America DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 47. North America DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 48. Europe DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 50. Europe DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 57. Global DNA Repair Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global DNA Repair Drugs Revenue by Region (2021-2026) & (US$ Million) Table 59. Global DNA Repair Drugs Revenue by Region (2027-2032) & (US$ Million) Table 60. Global DNA Repair Drugs Revenue Market Share by Region (2021-2026) Table 61. Global DNA Repair Drugs Revenue Market Share by Region (2027-2032) Table 62. Johnson & Johnson Company Information Table 63. Johnson & Johnson Business Overview Table 64. Johnson & Johnson DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Johnson & Johnson DNA Repair Drugs Product Portfolio Table 66. Johnson & Johnson Recent Development Table 67. Jiangsu Hengrui Medicine Company Information Table 68. Jiangsu Hengrui Medicine Business Overview Table 69. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio Table 71. Jiangsu Hengrui Medicine Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline DNA Repair Drugs Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Tesaro Company Information Table 78. Tesaro Business Overview Table 79. Tesaro DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Tesaro DNA Repair Drugs Product Portfolio Table 81. Tesaro Recent Development Table 82. National Institutes of Health Company Information Table 83. National Institutes of Health Business Overview Table 84. National Institutes of Health DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. National Institutes of Health DNA Repair Drugs Product Portfolio Table 86. National Institutes of Health Recent Development Table 87. National Health Service Company Information Table 88. National Health Service Business Overview Table 89. National Health Service DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. National Health Service DNA Repair Drugs Product Portfolio Table 91. National Health Service Recent Development Table 92. KuDOS Pharmaceuticals Company Information Table 93. KuDOS Pharmaceuticals Business Overview Table 94. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio Table 96. KuDOS Pharmaceuticals Recent Development Table 97. Karyopharm Therapeutics Company Information Table 98. Karyopharm Therapeutics Business Overview Table 99. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Karyopharm Therapeutics DNA Repair Drugs Product Portfolio Table 101. Karyopharm Therapeutics Recent Development Table 102. Jonsson Comprehensive Cancer Center Company Information Table 103. Jonsson Comprehensive Cancer Center Business Overview Table 104. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio Table 106. Jonsson Comprehensive Cancer Center Recent Development Table 107. German Breast Group Company Information Table 108. German Breast Group Business Overview Table 109. German Breast Group DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. German Breast Group DNA Repair Drugs Product Portfolio Table 111. German Breast Group Recent Development Table 112. Georgetown University Company Information Table 113. Georgetown University Business Overview Table 114. Georgetown University DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Georgetown University DNA Repair Drugs Product Portfolio Table 116. Georgetown University Recent Development Table 117. Genentech Company Information Table 118. Genentech Business Overview Table 119. Genentech DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Genentech DNA Repair Drugs Product Portfolio Table 121. Genentech Recent Development Table 122. Cambridge University Hospitals NHS Foundation Trust Company Information Table 123. Cambridge University Hospitals NHS Foundation Trust Business Overview Table 124. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio Table 126. Cambridge University Hospitals NHS Foundation Trust Recent Development Table 127. British Columbia Cancer Agency Company Information Table 128. British Columbia Cancer Agency Business Overview Table 129. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. British Columbia Cancer Agency DNA Repair Drugs Product Portfolio Table 131. British Columbia Cancer Agency Recent Development Table 132. Bristol Myers Squibb Company Information Table 133. Bristol Myers Squibb Business Overview Table 134. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Bristol Myers Squibb DNA Repair Drugs Product Portfolio Table 136. Bristol Myers Squibb Recent Development Table 137. ARCAGY/ GINECO GROUP Company Information Table 138. ARCAGY/ GINECO GROUP Business Overview Table 139. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio Table 141. ARCAGY/ GINECO GROUP Recent Development Table 142. 4SC AG Company Information Table 143. 4SC AG Business Overview Table 144. 4SC AG DNA Repair Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. 4SC AG DNA Repair Drugs Product Portfolio Table 146. 4SC AG Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. DNA Repair Drugs Distributors List Table 150. DNA Repair Drugs Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. DNA Repair Drugs Product Image Figure 2. Global DNA Repair Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Repair Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Repair Drugs Sales (2021-2032) & (K Units) Figure 5. Global DNA Repair Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 DNA Repair Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PARP Inhibitors Image Figure 9. Other Image Figure 10. Global DNA Repair Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global DNA Repair Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global DNA Repair Drugs Sales Market Share by Type (2021-2032) Figure 13. Global DNA Repair Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global DNA Repair Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global DNA Repair Drugs Revenue Market Share by Type (2021-2032) Figure 16. Oncological Image Figure 17. Stroke Image Figure 18. Global DNA Repair Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global DNA Repair Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global DNA Repair Drugs Sales Market Share by Application (2021-2032) Figure 21. Global DNA Repair Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global DNA Repair Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global DNA Repair Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America DNA Repair Drugs Sales Market Share by Country (2021-2032) Figure 26. U.S. DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe DNA Repair Drugs Sales Market Share by Country (2021-2032) Figure 31. Germany DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific DNA Repair Drugs Sales Market Share by Country (2021-2032) Figure 38. China DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2021-2032) Figure 46. Brazil DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile DNA Repair Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global DNA Repair Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global DNA Repair Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Figure 57. North America DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Figure 59. Europe DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa DNA Repair Drugs Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. DNA Repair Drugs Value Chain Figure 65. Manufacturing Cost Structure Figure 66. DNA Repair Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • PARP Inhibitors
  • Other
Applications
  • Oncological
  • Stroke
Companies covered
  • Johnson & Johnson
  • Jiangsu Hengrui Medicine
  • GlaxoSmithKline
  • Tesaro
  • National Institutes of Health
  • National Health Service
  • KuDOS Pharmaceuticals
  • Karyopharm Therapeutics
  • Jonsson Comprehensive Cancer Center
  • German Breast Group
  • Georgetown University
  • Genentech
  • Cambridge University Hospitals NHS Foundation Trust
  • British Columbia Cancer Agency
  • Bristol Myers Squibb
  • ARCAGY/ GINECO GROUP
  • 4SC AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Repair Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Repair Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global DNA Repair Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global DNA Repair Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global DNA Repair Drugs Market Dynamics
  1. 2.1 DNA Repair Drugs Industry Trends
  2. 2.2 DNA Repair Drugs Industry Drivers
  3. 2.3 DNA Repair Drugs Industry Opportunities and Challenges
  4. 2.4 DNA Repair Drugs Industry Restraints
3 DNA Repair Drugs Market by Manufacturers
  1. 3.1 Global DNA Repair Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global DNA Repair Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global DNA Repair Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global DNA Repair Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DNA Repair Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global DNA Repair Drugs Manufacturers, Product Type & Application
  7. 3.7 Global DNA Repair Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DNA Repair Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DNA Repair Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DNA Repair Drugs Tier 1, Tier 2, and Tier 3
4 DNA Repair Drugs Market by Type
  1. 4.1 DNA Repair Drugs Type Introduction
  2. 4.1.1 PARP Inhibitors
  3. 4.1.2 Other
  4. 4.2 Global DNA Repair Drugs Sales by Type
  5. 4.2.1 Global DNA Repair Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Repair Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global DNA Repair Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global DNA Repair Drugs Revenue by Type
  9. 4.3.1 Global DNA Repair Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DNA Repair Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global DNA Repair Drugs Revenue Market Share by Type (2021-2032)
5 DNA Repair Drugs Market by Application
  1. 5.1 DNA Repair Drugs Application Introduction
  2. 5.1.1 Oncological
  3. 5.1.2 Stroke
  4. 5.2 Global DNA Repair Drugs Sales by Application
  5. 5.2.1 Global DNA Repair Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DNA Repair Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global DNA Repair Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global DNA Repair Drugs Revenue by Application
  9. 5.3.1 Global DNA Repair Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DNA Repair Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global DNA Repair Drugs Revenue Market Share by Application (2021-2032)
6 Global DNA Repair Drugs Sales by Region
  1. 6.1 Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Repair Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global DNA Repair Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global DNA Repair Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America DNA Repair Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe DNA Repair Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific DNA Repair Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa DNA Repair Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa DNA Repair Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global DNA Repair Drugs Revenue by Region
  1. 7.1 Global DNA Repair Drugs Revenue by Region
  2. 7.1.1 Global DNA Repair Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global DNA Repair Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global DNA Repair Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global DNA Repair Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America DNA Repair Drugs Revenue (2021-2032)
  8. 7.2.2 North America DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe DNA Repair Drugs Revenue (2021-2032)
  11. 7.3.2 Europe DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific DNA Repair Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa DNA Repair Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa DNA Repair Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine
  8. 8.2.1 Jiangsu Hengrui Medicine Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Tesaro
  20. 8.4.1 Tesaro Company Information
  21. 8.4.2 Tesaro Business Overview
  22. 8.4.3 Tesaro DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tesaro DNA Repair Drugs Product Portfolio
  24. 8.4.5 Tesaro Recent Developments
  25. 8.5 National Institutes of Health
  26. 8.5.1 National Institutes of Health Company Information
  27. 8.5.2 National Institutes of Health Business Overview
  28. 8.5.3 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 National Institutes of Health DNA Repair Drugs Product Portfolio
  30. 8.5.5 National Institutes of Health Recent Developments
  31. 8.6 National Health Service
  32. 8.6.1 National Health Service Company Information
  33. 8.6.2 National Health Service Business Overview
  34. 8.6.3 National Health Service DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 National Health Service DNA Repair Drugs Product Portfolio
  36. 8.6.5 National Health Service Recent Developments
  37. 8.7 KuDOS Pharmaceuticals
  38. 8.7.1 KuDOS Pharmaceuticals Company Information
  39. 8.7.2 KuDOS Pharmaceuticals Business Overview
  40. 8.7.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
  42. 8.7.5 KuDOS Pharmaceuticals Recent Developments
  43. 8.8 Karyopharm Therapeutics
  44. 8.8.1 Karyopharm Therapeutics Company Information
  45. 8.8.2 Karyopharm Therapeutics Business Overview
  46. 8.8.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
  48. 8.8.5 Karyopharm Therapeutics Recent Developments
  49. 8.9 Jonsson Comprehensive Cancer Center
  50. 8.9.1 Jonsson Comprehensive Cancer Center Company Information
  51. 8.9.2 Jonsson Comprehensive Cancer Center Business Overview
  52. 8.9.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
  54. 8.9.5 Jonsson Comprehensive Cancer Center Recent Developments
  55. 8.10 German Breast Group
  56. 8.10.1 German Breast Group Company Information
  57. 8.10.2 German Breast Group Business Overview
  58. 8.10.3 German Breast Group DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 German Breast Group DNA Repair Drugs Product Portfolio
  60. 8.10.5 German Breast Group Recent Developments
  61. 8.11 Georgetown University
  62. 8.11.1 Georgetown University Company Information
  63. 8.11.2 Georgetown University Business Overview
  64. 8.11.3 Georgetown University DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Georgetown University DNA Repair Drugs Product Portfolio
  66. 8.11.5 Georgetown University Recent Developments
  67. 8.12 Genentech
  68. 8.12.1 Genentech Company Information
  69. 8.12.2 Genentech Business Overview
  70. 8.12.3 Genentech DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genentech DNA Repair Drugs Product Portfolio
  72. 8.12.5 Genentech Recent Developments
  73. 8.13 Cambridge University Hospitals NHS Foundation Trust
  74. 8.13.1 Cambridge University Hospitals NHS Foundation Trust Company Information
  75. 8.13.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
  76. 8.13.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
  78. 8.13.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
  79. 8.14 British Columbia Cancer Agency
  80. 8.14.1 British Columbia Cancer Agency Company Information
  81. 8.14.2 British Columbia Cancer Agency Business Overview
  82. 8.14.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
  84. 8.14.5 British Columbia Cancer Agency Recent Developments
  85. 8.15 Bristol Myers Squibb
  86. 8.15.1 Bristol Myers Squibb Company Information
  87. 8.15.2 Bristol Myers Squibb Business Overview
  88. 8.15.3 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
  90. 8.15.5 Bristol Myers Squibb Recent Developments
  91. 8.16 ARCAGY/ GINECO GROUP
  92. 8.16.1 ARCAGY/ GINECO GROUP Company Information
  93. 8.16.2 ARCAGY/ GINECO GROUP Business Overview
  94. 8.16.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
  96. 8.16.5 ARCAGY/ GINECO GROUP Recent Developments
  97. 8.17 4SC AG
  98. 8.17.1 4SC AG Company Information
  99. 8.17.2 4SC AG Business Overview
  100. 8.17.3 4SC AG DNA Repair Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 4SC AG DNA Repair Drugs Product Portfolio
  102. 8.17.5 4SC AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DNA Repair Drugs Value Chain Analysis
  2. 9.1.1 DNA Repair Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DNA Repair Drugs Production Mode & Process
  6. 9.2 DNA Repair Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DNA Repair Drugs Distributors
  9. 9.2.3 DNA Repair Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst